Biosensors International Group, Ltd

Biosensors International Group, Ltd. is a medical device company based in Singapore, specializing in innovative technologies for interventional cardiology and critical care. Founded in 1990, the company has manufacturing and research facilities in Singapore, a European headquarters in Morges, Switzerland, and an R&D center in Irvine, California. The company is known for its expertise in cardiovascular stent technologies, particularly drug-eluting stents (DES). Its flagship product, the BioMatrix stent, features a biodegradable polymer coating and a proprietary drug, Biolimus A9™, designed to enhance patient outcomes. Biosensors has developed successive generations of DES, improving their deliverability and flexibility. In addition to stents, the company also offers critical care catheter systems and devices for heart surgery and intensive care. Biosensors serves a global healthcare community through direct sales and distributors, and it actively supports medical education by organizing training and scientific events. The company also licenses its technologies to other medical device firms and has a joint venture in Hong Kong for marketing coronary stents in China.

• Employees 460
• Founded 1990
• Annual Revenue $127000000